Research on the role Fusobacterium nucleatum plays in cancer shows that the transcriptome and epigenome of different host cell types are affected by the pathogen in different ways.
As the COVID-19 pandemic continues, public health authorities around the world are facing a significant challenge: ensuring a large enough supply of reagents to scale-up diagnostic testing. Researchers at Canada's Michael Smith Genome Sciences Centre at BC Cancer (GSC), the University of British Columbia (UBC) and the BC Centre for Disease Control (BCCDC) are working to develop new non-proprietary reagents to support current and future testing in British Columbia.
Researchers have developed a rapid and highly sensitive method for ensuring cell-based cancer therapies are contaminant-free.
Harnessing the power of our own immune systems can help fight off cancer. Researchers at the BC Cancer Genome Sciences Centre have developed a method to tell immune cells exactly what to look for